WASHINGTON — The Trump administration has started quietly rehiring some of the Food and Drug Administration employees it fired last week, according to nine agency sources, shortly after letting them go in a process that insiders described as abrupt and haphazard.
The total number of employees rehired is unclear, but in at least some cases the reinstatements appeared to be broad. All 12 of the people who worked in the office reviewing surgical and infection control devices were reinstated, an agency source said. Two of three people in the FDA’s digital health office who had been let go were rehired, as were a handful of employees reviewing AI-enabled imaging devices, diabetes devices and cardiovascular devices, according to four other agency sources.
Neither the FDA nor the Health and Human Services Department, which oversees the agency, responded to STAT’s request for more information.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
